Somatic mutations in IDH1 and IDH2 have been demonstrated in many human cancers including low grade glioma, glioblastoma, cholangiocarcinoma, chondrosarcoma, and acute myeloid leukemia as recently summarized [5]. Here, IDH2 is linked to glioma.